Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats.Neurosci Res. 2014 Jul; 84:60-3.NR
Abstract
Cannabidiol (CBD) is a constituent of Cannabis sativa that promotes wakefulness as well as enhances endogenous levels of wake-related neurotransmitters, including dopamine. However, at this date, the effects of CBD on the sleep-inducing molecules, such as adenosine (AD), are unknown. Here, we report that intrahypothalamic injection of CBD (10μg/1μL) increases the extracellular levels of AD collected from nucleus accumbens. Furthermore, the pharmacodynamic of this drug shows that effects on the contents of AD last 2h post-injection. These preliminary findings suggest that CBD promotes the endogenous accumulation of AD.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
24800644
Citation
Mijangos-Moreno, Stephanie, et al. "Intrahypothalamic Injection of Cannabidiol Increases the Extracellular Levels of Adenosine in Nucleus Accumbens in Rats." Neuroscience Research, vol. 84, 2014, pp. 60-3.
Mijangos-Moreno S, Poot-Aké A, Arankowsky-Sandoval G, et al. Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. Neurosci Res. 2014;84:60-3.
Mijangos-Moreno, S., Poot-Aké, A., Arankowsky-Sandoval, G., & Murillo-Rodríguez, E. (2014). Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. Neuroscience Research, 84, 60-3. https://doi.org/10.1016/j.neures.2014.04.006
Mijangos-Moreno S, et al. Intrahypothalamic Injection of Cannabidiol Increases the Extracellular Levels of Adenosine in Nucleus Accumbens in Rats. Neurosci Res. 2014;84:60-3. PubMed PMID: 24800644.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats.
AU - Mijangos-Moreno,Stephanie,
AU - Poot-Aké,Alwin,
AU - Arankowsky-Sandoval,Gloria,
AU - Murillo-Rodríguez,Eric,
Y1 - 2014/05/04/
PY - 2014/02/20/received
PY - 2014/04/01/revised
PY - 2014/04/22/accepted
PY - 2014/5/8/entrez
PY - 2014/5/8/pubmed
PY - 2015/6/9/medline
KW - Adenosine
KW - HPLC
KW - Hypothalamus
KW - Microdialysis
KW - Wakefulness
SP - 60
EP - 3
JF - Neuroscience research
JO - Neurosci Res
VL - 84
N2 - Cannabidiol (CBD) is a constituent of Cannabis sativa that promotes wakefulness as well as enhances endogenous levels of wake-related neurotransmitters, including dopamine. However, at this date, the effects of CBD on the sleep-inducing molecules, such as adenosine (AD), are unknown. Here, we report that intrahypothalamic injection of CBD (10μg/1μL) increases the extracellular levels of AD collected from nucleus accumbens. Furthermore, the pharmacodynamic of this drug shows that effects on the contents of AD last 2h post-injection. These preliminary findings suggest that CBD promotes the endogenous accumulation of AD.
SN - 1872-8111
UR - https://www.unboundmedicine.com/medline/citation/24800644/Intrahypothalamic_injection_of_cannabidiol_increases_the_extracellular_levels_of_adenosine_in_nucleus_accumbens_in_rats_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0168-0102(14)00071-6
DB - PRIME
DP - Unbound Medicine
ER -